Добро пожаловать
Нажатие «Авторизоваться» означает, что вы соглашаетесь с Условия использования и политика конфиденциальности Cointime.
Зарегистрировать аккаунт
Аккаунт уже существует?
Нажатие «page.Sign up» означает, что вы соглашаетесь с <a class="underline" href="#term-of-service">Условия использования</a> и a class="underline" href="#privacy-policy">политика конфиденциальности</a> Cointime.
Войдите, используя email
Зарегистрируйтесь с помощью email
твой почтовый ящик
Проверь свои входящие
Нажмите на ссылку в , чтобы войти.
Нажмите на ссылку в , чтобы зарегистрироваться.
NS Investment
company
About
NS Investment (NSI) is an affiliated firm of Dong-A ST, a leading pharmaceutical company.
Highlights
Details
- Founded date
- Jan 1, 2016
- Operating Status
- Active
- Investor Type
- Venture Capital
NS Investment (NSI) is an affiliated firm of Dong-A ST, a leading pharmaceutical company in the Republic of Korea. NSI was established in 2015 to independently manage venture capital funds and serve institutional investors in Korea. NSI is focused on meeting the financial objective of its fund investors. NSI seeks to link Korean investor capital with innovative companies beyond its domestic boarders and ultimately link entrepreneurs and science across continents.
Investments
Number of Investments
Number of Lead Investments
3
0
NS Investment has made 3 investments. Their most recent investment was on
May 9, 2022, when Aspen Neuroscience raised $147.50M.
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
May 9, 2022
Aspen Neuroscience
|
Series B | $147.50M | Biotechnology | — |
|
Oct 21, 2021
ReCode Therapeutics
|
Series B | $210M | Biopharma | — |
|
Feb 21, 2018
ORIC Pharmaceuticals
|
Series C | $50M | Biotechnology | — |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
